QIAGEN powered by
How to track the progress of ERBB2-targeted therapies from early case studies to market with COSMIC Actionability

QIAGEN Digital Insights Monday, April 25, 2022

The latest COSMIC Actionability release is here with a focus on the ERBB2 gene. Before we delve into the trove…

Digging for rare finds – two breast cancer publications to keep a watch for in V95

QIAGEN Digital Insights Tuesday, February 1, 2022

While the world showed its support for affected people during Breast Cancer Awareness Month, COSMIC’s expert curators were working hard…

Manual curation in the age of automation: 4 reasons why COSMIC remains the gold standard database

QIAGEN Digital Insights Wednesday, November 17, 2021

As the technology revolution rages on, the age-old battle rears its head: old vs. new, computers vs. people, tried-and-tested vs….

5 reasons why you should use COSMIC to identify cancer mutations

QIAGEN Digital Insights Friday, May 7, 2021

COSMIC, the Catalogue Of Somatic Mutations In Cancer, is the world’s largest and most comprehensive resource for exploring the impact…

COSMIC – Powering Precision Oncology Research and Development

QIAGEN Digital Insights Thursday, April 1, 2021

Around two decades ago, the amount of data about cancer genomes began to increase rapidly. Managing, viewing, and searching for…